MiR-29c inhibits HCV replication<i>via</i>activation of type I IFN response by targeting STAT3 in JFH-1-infected Huh7 cells

Yanjing Wang(Henan University Huaihe Hospital and Huaihe Clinical Institute), Yuanyuan Li(Zhejiang Chinese Medical University)
RSC Advances
January 1, 2018
Cited by 11


Related Papers